BridgeMD
New treatment option for Dysmenorrhea
Official title Electroacupuncture for Dysmenorrhea Secondary to Adenomyosis
ClinicalTrials.gov ID: NCT06364592
What this study is testing
- What it's testing
- The aim of this study is to preliminarily evaluate the is to assess the effects and safety of electroacupuncture for moderate to severe dysmenorrhea secondary to adenomyosis.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50, women only
You may be able to join if
- Meeting the diagnosis criteria of dysmenorrhea secondary to adenomyosis.
- Female patients aged between 18 and 50.
- Dysmenorrhea lasting for 3 consecutive menstrual cycles or more.
- At least three consecutive menstrual cycles with an interval of 24 to 38 days, differing by less than 7 days, and menstrual periods lasting 2 to 8...
- At least 2 days of worst pain score ≥4 on Numerical Rating Scale during the screening period.
You likely can't join if
- Diagnosed with Endometriosis or having a history of endometriosis-related surgery
- Currently taking hormonal medications, including: a.use of GnRH agonists within 6 months before the screening period; b. use of progestins or danazol...
- Having clinically significant gynecologic condition such as clinically significant endometrial pathology, persistent complex ovarian cyst larger than...
- having an IUD.
- HB \< 90G/L.
- Having any other chronic pain syndrome that required chronic analgesic or other chronic therapy.
See the full eligibility criteria
- Meeting the diagnosis criteria of dysmenorrhea secondary to adenomyosis.
- Female patients aged between 18 and 50.
- Dysmenorrhea lasting for 3 consecutive menstrual cycles or more.
- At least three consecutive menstrual cycles with an interval of 24 to 38 days, differing by less than 7 days, and menstrual periods lasting 2 to 8 days before screening.
- At least 2 days of worst pain score ≥4 on Numerical Rating Scale during the screening period.
- Having not used medications, other than rescue medicine, or therapies for dysmenorrhea secondary to adenomyosis for at least 1 month before randomization, and consenting not to use throughout the process of the research.
- Volunteering to participate the trial and signing written informed consent.
- Diagnosed with Endometriosis or having a history of endometriosis-related surgery
- Currently taking hormonal medications, including: a.use of GnRH agonists within 6 months before the screening period; b. use of progestins or danazol and other long-acting hormones within 3 months before the screening...
- Having clinically significant gynecologic condition such as clinically significant endometrial pathology, persistent complex ovarian cyst larger than 3 cm or simple ovarian cyst larger than 5 cm, or single fibroid 4 cm...
- having an IUD.
- HB \< 90G/L.
- Having any other chronic pain syndrome that required chronic analgesic or other chronic therapy.
- Having a current history of undiagnosed abnormal genital bleeding.
- Malignant tumors (including the reproductive system and other systems).
- Combined with severe diseases in the cardiac, respiratory, renal, liver, and hematopoietic systems, psychiatric disorder and/or cognitive disorders.
- Pregnant, breast feeding, planning a pregnancy within the next 7 months.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.